All In Biotech

Drug Trial Radar · NCT01022580

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide

Last checked: Nov 20, 2026Latest source record: May 13, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 511 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

511

Actual

Start

Jan 2010

Primary completion

Dec 2013

Study completion Jan 2016

Sponsor

Lead sponsor
Roberta BallardAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Dec 1, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 7 days, up to 14 days
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if late doses of Infasurf surfactant given when patients are receiving inhaled nitric oxide will interact to improve surfactant function and increase survival without BPD in treated infants.

Conditions

  • Bronchopulmonary Dysplasia

Interventions

  • Infasurf surfactant (ONY, Inc.)Drug

    Late doses of Infasurf 3ml/kg will be given to infants on study days 0, 2, 4, 6 and 8 as long as infant remains intubated.

  • Sham (No Treatment)Drug

    Late doses of Sham (No treatment) will be given to infants on study days 0, 2, 4, 6 and 8 as long as infant remains intubated.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival Without BPD at 36 Weeks Post Menstrual Age.Time frame: 36 weeks post menstrual age +/- 1 week

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • University of Arkansas - Arkansas Childrens Hospital

    Little Rock, Arkansas

  • Alta Bates Medical Center

    Berkeley, California

  • Oakland Children's Hospital

    Oakland, California

  • University of California, San Francisco

    San Francisco, California

  • Wolfson Children's Hospital and Shands HospitaL

    Jacksonville, Florida

  • Florida Hospital for Children

    Orlando, Florida

  • All Children's Hospital

    St. Petersburg, Florida

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Children's Memorial Hospital

    Chicago, Illinois

  • Childrens Hospital and Clinics of Minnesota- Minneapolis

    Minneapolis, Minnesota

  • University of Minnesota Medical School

    Minneapolis, Minnesota

  • Children's Hospital and Clinics of Minnesota - St Paul

    Saint Paul, Minnesota

  • Children's Mercy Hospital

    Kansas City, Missouri

  • Women's and Children's Hospital of Buffalo

    Buffalo, New York

  • Stony Brook University Medical Center

    Stony Brook, New York

  • Wake Forest University- Forsyth Hospital and Brenner Hospital

    Winston-Salem, North Carolina

  • Medical University of South Carolina(MUSC)

    Charleston, South Carolina

  • UT Memphis- Memphis Medical Center

    Memphis, Tennessee

  • UT Houston Health Science Center

    Houston, Texas

  • Texas Children's Hospital

    Houston, Texas

  • University of Washington, Seattle

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.